| 000 | 01528 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513193003.0 | ||
| 264 | 0 | _c19991026 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1053/hj.1999.v138.a100464 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTcheng, J E | |
| 245 | 0 | 0 |
_aA symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cOct 1999 |
||
| 300 |
_a261-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAngina, Unstable _xdrug therapy |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 773 | 0 |
_tAmerican heart journal _gvol. 138 _gno. 4 Pt 2 _gp. 261-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/hj.1999.v138.a100464 _zAvailable from publisher's website |
| 999 |
_c10459383 _d10459383 |
||